IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

LOMBARDI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 6.895
EU - Europa 6.839
NA - Nord America 6.657
SA - Sud America 860
AF - Africa 181
OC - Oceania 81
Continente sconosciuto - Info sul continente non disponibili 1
Totale 21.514
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.186
IT - Italia 2.313
CN - Cina 1.887
SG - Singapore 1.870
DE - Germania 1.354
VN - Vietnam 668
BD - Bangladesh 647
GB - Regno Unito 636
HK - Hong Kong 623
BR - Brasile 603
SE - Svezia 565
RU - Federazione Russa 472
IN - India 339
NL - Olanda 295
FR - Francia 292
CA - Canada 285
FI - Finlandia 197
ID - Indonesia 179
IE - Irlanda 167
TR - Turchia 131
MX - Messico 122
ES - Italia 113
JP - Giappone 109
KR - Corea 105
AR - Argentina 79
AU - Australia 76
CI - Costa d'Avorio 68
AT - Austria 63
PL - Polonia 56
CO - Colombia 52
IQ - Iraq 40
PK - Pakistan 38
BE - Belgio 37
EC - Ecuador 37
CH - Svizzera 34
RO - Romania 34
CL - Cile 32
PH - Filippine 31
TW - Taiwan 31
ZA - Sudafrica 30
GR - Grecia 26
DK - Danimarca 25
IR - Iran 24
VE - Venezuela 24
TH - Thailandia 23
UA - Ucraina 23
CZ - Repubblica Ceca 21
SA - Arabia Saudita 20
PE - Perù 19
EG - Egitto 18
PT - Portogallo 18
MA - Marocco 15
HU - Ungheria 14
JO - Giordania 13
UZ - Uzbekistan 13
RS - Serbia 12
AE - Emirati Arabi Uniti 10
LT - Lituania 10
MY - Malesia 10
NP - Nepal 10
NO - Norvegia 9
DZ - Algeria 8
IL - Israele 8
KE - Kenya 8
SC - Seychelles 8
DO - Repubblica Dominicana 7
HR - Croazia 7
KZ - Kazakistan 7
OM - Oman 7
PA - Panama 7
PY - Paraguay 7
AL - Albania 6
AZ - Azerbaigian 6
BG - Bulgaria 6
CR - Costa Rica 6
GT - Guatemala 6
JM - Giamaica 6
KG - Kirghizistan 6
NG - Nigeria 6
SV - El Salvador 6
TN - Tunisia 6
BY - Bielorussia 5
ET - Etiopia 5
HN - Honduras 5
KH - Cambogia 5
LU - Lussemburgo 5
PS - Palestinian Territory 5
SK - Slovacchia (Repubblica Slovacca) 5
BB - Barbados 4
BO - Bolivia 4
CU - Cuba 4
LB - Libano 4
MD - Moldavia 4
NZ - Nuova Zelanda 4
TJ - Tagikistan 4
AM - Armenia 3
CY - Cipro 3
EE - Estonia 3
GE - Georgia 3
LV - Lettonia 3
Totale 21.465
Salva come PNG Salva come JPEG
Città #
Singapore 1.035
Ashburn 984
Hanover 761
Milan 584
Hong Kong 526
Chandler 491
San Jose 415
Southend 369
Dallas 329
Frankfurt am Main 262
Santa Clara 257
Beijing 255
Council Bluffs 255
Los Angeles 250
New York 215
Hefei 195
Ho Chi Minh City 161
Dublin 158
Hanoi 158
Toronto 156
Rome 151
Princeton 136
Helsinki 134
Jakarta 130
Boardman 117
Fairfield 106
Lauterbourg 102
Bengaluru 98
Guangzhou 91
Moscow 90
São Paulo 89
Buffalo 85
Istanbul 83
Shanghai 81
Abidjan 68
Dong Ket 68
Munich 67
The Dalles 65
Chicago 64
Houston 64
Seoul 64
Turin 64
Tokyo 59
Phoenix 56
Columbus 55
Nuremberg 54
Wilmington 54
Cambridge 53
Ann Arbor 51
Cangzhou 51
Atlanta 47
Berlin 44
Naples 43
London 41
Da Nang 40
Pavia 40
Seattle 40
Lappeenranta 36
Montreal 36
Des Moines 35
Genoa 35
Bologna 34
Warsaw 34
Florence 33
Rio de Janeiro 31
Tianjin 31
Amsterdam 30
Boston 30
Woodbridge 30
Brussels 29
Haiphong 29
Nanjing 29
Washington 29
Brooklyn 27
Chennai 26
Denver 26
Madrid 26
Redwood City 26
Mexico City 25
Orem 23
Pontedera 23
Verona 23
Vienna 23
Wuhan 23
San Diego 22
Turku 22
Sydney 21
Manchester 20
Bari 19
Bogotá 19
Quanzhou 19
Central 18
Chengdu 18
Kent 18
Changsha 17
Dearborn 17
Palermo 17
Piscataway 17
Poplar 17
Buenos Aires 16
Totale 11.640
Salva come PNG Salva come JPEG
Nome #
Hepatitis C: Is eradication possible? 1.189
Deficient natural killer cell NKp30-mediated function and altered NCR3 splice variants in hepatocellular carcinoma 717
A clinical case of sepsis due to staphylococcus pettenkoferi 598
Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients 583
Exosomes Recovered From the Plasma of COVID-19 Patients Expose SARS-CoV-2 Spike-Derived Fragments and Contribute to the Adaptive Immune Response 415
Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: an observational cohort study 378
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy 376
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort 320
Response of an Italian reference institute to research challenges regarding a new pandemic: COVID-19 network 314
Anti-spike antibodies and neutralising antibody activity in people living with HIV vaccinated with COVID-19 mRNA-1273 vaccine: a prospective single-centre cohort study 310
Early Phases of COVID-19 Are Characterized by a Reduction in Lymphocyte Populations and the Presence of Atypical Monocytes 271
Duration of quarantine in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a question needing an answer 264
The impact of HIV infection and men who have sex with men status on hepatitis A infection: The experience of two tertiary centres in Northern Italy during the 2017 outbreak and in the 2009-2016 period 259
COVID-19: What happened to the healthcare workers of a research and teaching hospital in Milan, Italy? 252
Production of anti-{PF}4 antibodies in antiphospholipid antibody-positive patients is not affected by {COVID}-19 vaccination 235
Mucormycosis in CAPA, a possible fungal super-infection 234
Characteristics of 1573 healthcare workers who underwent nasopharyngeal swab testing for SARS-CoV-2 in Milan, Lombardy, Italy 225
Multidrug‐resistant gram‐negative bacteria decolonization in immunocompromised patients : a focus on fecal microbiota transplantation 223
Antiviral Treatments for Influenza 219
Integrase inhibitors use and CMV infection predict immune recovery in peolple living with HIV starting first-line therapy 218
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy : comment 215
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting 214
Congenital Hepatic Fibrosis as a Cause of Recurrent Cholangitis: A Case Report and Review of the Literature 213
SARS-CoV-2 anti-spike antibody titres after vaccination with BNT162b2 in naïve and previously infected individuals 213
Mini Review Immunological Consequences of Immunization With COVID-19 mRNA Vaccines: Preliminary Results 210
A Response to: Letter to the Editor Regarding Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP) 209
Incidence, microbiological and immunological characteristics of ventilator-associated pneumonia assessed by bronchoalveolar lavage and endotracheal aspirate in a prospective cohort of COVID-19 patients: CoV-AP study 206
Epidemiology, Clinical Manifestations, and Outcome of Mucormycosis in Solid Organ Transplant Recipients: A Systematic Review of Reported Cases 205
Vaccination with COVID-19 mRNA-1273 is not associated with HIV-RNA blips among people with HIV on ART: a retrospective cohort study 205
Lack of Siglec-7 expression identifies a dysfunctional natural killer cell subset associated with liver inflammation and fibrosis in chronic HCV infection 205
Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis 205
ITPA and SLC29A1 Genotyping for the Prediction of Ribavirin Dose Reduction in Anti-HCV Triple Therapy with Protease Inhibitors 203
New Antibiotics Against Multidrug-Resistant Gram-Negative Bacteria in Liver Transplantation: Clinical Perspectives, Toxicity, and PK/PD Properties 201
Immune checkpoint inhibitors in people living with HIV/AIDS : facts and controversies 201
Anterior uveitis onset after bnt162b2 vaccination: is this just a coincidence? 200
Long-term dynamics of natural killer cells in response to SARS-CoV-2 vaccination: Persistently enhanced activity postvaccination 199
Perfusion fluid-related infections in liver transplant recipients: A 5-year, single-center, retrospective study 199
Detection of liver steatosis with a novel ultrasound-based technique : A pilot study using MRI-derived proton density fat fraction as the gold standard 199
Clinical characteristics of healthcare workers with SARS-CoV-2 infection after vaccination with BNT162b2 vaccine 199
Seroprevalence of anti-SARS-CoV-2 IgG among healthcare workers of a large university hospital in Milan, Lombardy, Italy: A cross-sectional study 198
Nasopharyngeal Testing among Healthcare Workers (HCWs) of a Large University Hospital in Milan, Italy during Two Epidemic Waves of COVID-19 195
Renal safety in 3264 HCV patients treated with DAA-based regimens : results from a large Italian real-life study 194
Pulmonary embolism in a young pregnant woman with COVID-19 192
A new algorithm shows superior ability to discriminate liver fibrosis stages in chronic hepatitis C 191
Characteristics of 1,573 healthcare workers who underwent nasopharyngeal swab for SARS-CoV-2 in Milano, Lombardy, Italy 191
Increased risk of urticaria/angioedema after BNT162b2 mRNA COVID-19 vaccine in health care workers taking ACE inhibitors 189
Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous daa failure 184
Air pollution exposure, SARS-CoV-2 infection, and immune response in a cohort of healthcare workers of a large university hospital in Milan, Italy 183
Innate and adaptive lymphocytes in non-tuberculous mycobacteria lung disease : A review 182
Inflammatory biomarkers in pregnant women with COVID-19: a retrospective cohort study 182
Tracking the immune response profiles elicited by the BNT162b2 vaccine in COVID-19 unexperienced and experienced individuals 179
Transient increase in plasma HIV RNA after COVID-19 vaccination with mRNA-1272 177
Preliminary Evidence of Good Safety Profile and Outcomes of Early Treatment With Tixagevimab/Cilgavimab Compared to Previously Employed Monoclonal Antibodies for COVID-19 in Immunocompromised Patients 175
Preliminary Evidence of Good Safety Profile and Outcomes of Early Treatment with Tixagevimab/Cilgavimab Compared to Previously Employed Monoclonal Antibodies for COVID-19 in Immunocompromised Patients 173
Dealing With Antibiotic Prophylaxis in Lung Transplantation in the Era of Multidrug Resistance: The Milano Algorithm 173
Clinical risk scores for the early prediction of severe outocomes in patients hospitalized for {COVID}-19: comment 172
Treatment of 320 genotype 3 cirrhotic patients with 12 weeks Sofosbuvir/Velpatasvir with or without ribavirin: real life experience from Italy 168
COVID-19 Vaccine in Lung and Liver Transplant Recipients Exceeds Expectations: An Italian Real-Life Experience on Immunogenicity and Clinical Efficacy of BNT162b2 Vaccine 166
Clinical Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP) 166
Mortality in KPC-producing Klebsiella pneumoniae bloodstream infections: a changing landscape 163
T-cell exhaustion in mycobacterium tuberculosis and nontuberculous mycobacteria infection : Pathophysiology and therapeutic perspectives 160
Safety Profile and Outcomes of Early COVID-19 Treatments in Immunocompromised Patients: A Single-Centre Cohort Study 157
Predictors of starting antimicrobial treatment in patients with nontuberculous mycobacterial lung disease in the Italian scenario: a SITA GIOVANI-IRENE promoted web-survey 155
Re: 'Which trial do we need? Culture of preservation fluid in abdominal-organ transplant recipients' by Manuel et al 153
Pneumocystis jirovecii pneumonia in HIV-negative patients, a frequently overlooked problem. A case series from a large Italian center 152
Antiviral treatment selection for SARS-CoV-2 pneumonia 150
Prophylaxis of spontaneous bacterial peritonitis : Is there still room for quinolones? 150
Carbapenem or new β-lactam-β-lactamase inhibitors? An Italian survey supported by SITA, SIMIT and SIAARTI to identify the factors affecting empiric antimicrobial therapy choice in real-life clinical practice 149
Side effects among healthcare workers from a large Milan university hospital after second dose of BNT162b2 mRNA COVID-19 vaccine 149
Infectious events in patients treated with immune checkpoint inhibitors, chimeric antigen receptor T cells and Bi-specific T-cell engagers: a review of registration studies 147
Increase in invasive group A streptococcal infections in Milan, Italy: a genomic and clinical characterization 147
Prospective Study on Incidence, Risk Factors and Outcome of Recurrent Clostridioides difficile Infections 145
Application of Syndromic Panels for respiratory Tract Infections in Lung Transplantation: A Critical Review on Current Evidence and Future Perspectives 144
The Interplay between Gut Microbiota and the Immune System in Liver Transplant Recipients and Its Role in Infections 143
Treatable traits and challenges in the clinical management of non-tuberculous mycobacteria lung disease in people with cystic fibrosis 141
Comments on PD-1 Inhibitor for Disseminated Mycobacterium avium Infection in a Person Living With HIV 137
The possible role of gut microbiota and microbial translocation profiling during chemo-free treatment of lymphoid malignancies 137
The COVID-19 pandemic preparedness ... or lack thereof: from China to Italy 133
RE : Effects of Long-Term Norfloxacin Therapy in Patients With Advanced Cirrhosis 131
Non-tuberculous mycobacteria lung disease due to Mycobacterium chimaera in a 67-year-old man treated with immune checkpoint inhibitors for lung adenocarcinoma: infection due to dysregulated immunity? 128
Untargeted Mass Spectrometry Approach to Study SARS-CoV-2 Proteins in Human Plasma and Saliva Proteome 127
What is the impact of SARS-CoV-2 pandemic on antimicrobial stewardship programs (ASPs)? The results of a survey among a regional network of infectious disease centres 126
Cefiderocol therapy among immunocompromised adult patients: a descriptive analysis from a prospective, multicentre cohort study 125
Mortality of Patients With Candidemia and COVID-19: A Systematic Review With Meta-analysis 123
Endogenous antibody response to SARS-CoV-2 in patients who received monoclonal antibodies against COVID-19: A systematic review 122
Spike-specific humoral and cellular immune responses after COVID-19 mRNA vaccination in patients with cirrhosis: A prospective single center study 122
Patients with chronic hepatitis C receiving treatment with direct acting antivirals: How is this population changing? 122
Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS Investigation 121
Impact of chemotherapy on humoral and cellular immune responses to COVID-19 vaccination in patients with solid tumors 117
The use of intrahepatic portosystemic shunt in HIV positive patients : A retrospective multicentric study 116
Hypothermic oxygenated machine-perfusion fluid-related infection in a liver transplant recipient: First case report in the literature 116
The impact of rifaximin in the prevention of bacterial infections in cirrhosis 114
How to tailor recommendations on the treatment of multi-drug resistant Gram-negative infections at country level integrating antibiotic stewardship principles within the GRADE-ADOLOPMENT framework 113
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 113
Non-tuberculous mycobacterial infections during cancer therapy with immune checkpoint inhibitors: a systematic review 112
An eight-year experience of Nocardia infection in Italy: does immunosuppression matter? 109
Early Onset Mycoplasma spp. Infection After Kidney Transplantation: A Systematic Review 107
Review article : immune checkpoint inhibitors and the liver, from therapeutic efficacy to side effects 106
Immunogenicity and effectiveness of BNT162b2 COVID-19 vaccine in a cohort of healthcare workers in Milan (Lombardy Region, Northern Italy) 103
Is a radiological score needed to define the severity of Nontuberculous mycobacteria lung disease? 100
Totale 20.516
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.942
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.942
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.843 49 72 108 113 154 178 463 581 429 211 159 326
2022/20232.177 254 244 154 197 184 294 94 152 220 91 212 81
2023/20242.018 102 121 126 142 433 193 165 107 98 98 204 229
2024/20254.305 224 345 152 335 245 261 268 398 288 487 535 767
2025/20269.596 869 647 911 761 757 525 1.294 431 864 635 1.050 852
2026/2027187 187 0 0 0 0 0 0 0 0 0 0 0
Totale 22.119